Healthcare | November 18, 2022
Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Subscribe To Our Newsletter & Stay Updated
